Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spectrila in Adult Subjects With Newly Diagnosed Acute B-Cell Lymphoblastic Leukaemia
NCT03156790Phase 2Terminated
- Sponsor
- medac GmbH
- Start
- Apr 2019
- Primary completion
- Nov 2025
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Asparaginase in Acute B-cell lymphoblastic leukemia (B-ALL), sponsored by medac GmbH. Started Apr 2019; status: terminated.
02
Drugs
Asparaginase
03
Conditions
Acute B-cell lymphoblastic leukemia (B-ALL)
Beyond the preview
Go deeper on NCT03156790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03156790.